Immune Hormones (Cytokines); Pathogenic Role in Autoimmune Rheumatic and Endocrine Diseases

References

• Bendtzen K. Lymphokines in inflammation. Inflammation Basic Mechanisms Tissue Injuring Principles and Clinical Models, P Venge, A Lindbom. Almqvist & Wiksell International, Stockholm 1985; 187–217
   Google Scholar
• Wilkin T J, Stutchfield P, Smith C S, Heaf DP. Autoimmunity, diabetes, and cystic fibrosis. Lancet 1987; ii: 157
   Google Scholar
• Padula S J, Clark R B, Korn JH. Cell-mediated immunity in rheumatic disease. Human Pathol 1986; 17: 254–263
   PubMed Web of Science ®Google Scholar
• Bunning R AD, Richardson H J, Crawford A, Skjødt H, Hughes D, Evans D B, Gowen M, Dobson P RM, Brown B L, Russell R GG. The effect of interleukin-1 on connective tissue metabolism and its relevance to arthritis. Agents Actions 1986; 18: 131–153
   PubMedGoogle Scholar
• Pujol J P, Loyau G. Interleukin-1 and osteoarthritis. Life Sci 1987; 41: 1187–1198
   PubMed Web of Science ®Google Scholar
• Sibley R K, Sutherland D ER, Goetz F, Michael AF. Recurrent diabetes mellitus in the pancreas iso-and allograft. A light and electron microscopic and immunohistochemical analysis of four cases. Lab Invest 1985; 53: 132–144
   PubMed Web of Science ®Google Scholar
• Rossini A A, Mordes J P, Like AA. Immunology of insulin-dependent diabetes mellitus. Ann Rev Immunol 1985; 3: 289–320
   PubMed Web of Science ®Google Scholar
• Ciclosporin in autoimmune diseases, R Schindler. Springer-Verlag, Berlin 1985
   Google Scholar
• Svejgaard A, Platz P, Ryder LP. HLA and disease susceptibility: Clinical implications. Clin Immunol Allergol 1984; 4: 567–580
   Google Scholar
• Bottazzo G F, Dean B M, McNally J M, MacKay E H, Swift G F, Gamble DR. In situ characterization of autoimmune phenomena and expression of HLA molecules in the pancreas in diabetic insulitis. N Engl J Med 1985; 313: 353–360
   PubMed Web of Science ®Google Scholar
• Hanafusa T, Chiovato L, Doniach D, Pujol-Borrell R, Russell R CG, Bottazzo GF. Aberrant expression of HLA-DR antigen on thyrocytes in Graves' disease: relevance for autoimmunity. Lancet 1983; 2: 1111–1115
   PubMed Web of Science ®Google Scholar
• Pujol-Borrell R, Todd I, Doshi M, Bottazzo G F, Sutton R, Gray D, Adolf G R, Feldmann M. HLA class II induction in human islet cells by interferon-γ plus tumour necrosis factor or lymphotoxin. Nature 1987; 326: 304–306
   PubMed Web of Science ®Google Scholar
• Trinchieri G, Perussia B. Immune interferon: a pleiotrophic lymphokine with multiple effects. Immunol Today 1985; 6: 131–136
   PubMedGoogle Scholar
• Iwatani Y, Gerstein H C, Iitaka M, Row V V, Volpe R. Thyrocyte HLA-DR expression and interferon-production in autoimmune thyroid disease. J Clin Endocrinol Metab 1986; 63: 695–708
   PubMed Web of Science ®Google Scholar
• Baird J D, Bone A J, Walker R, Cooke A. MHC antigen expression in the pancreas. Nature 1987; 329: 493–494
   PubMed Web of Science ®Google Scholar
• Bendtzen K. Interleukin 1 and tumor necrosis factor: Prototypes of macrophage hormones Highlights on Endocrinology. Proc. 1st. Eur. Congr. Endocrinol, C Christiansen, BJ Riis. Copenhagen 1987; 291–300
   Google Scholar
• Bendtzen K. Non-immunologlobulin peptide mediators of immune responses Highlights on Endocrinology. Proc. 1st. Eur. Congr. Endocrinol, C Christiansen, BJ Riis. Copenhagen 1987; 301–308
   Google Scholar
• Oschilewski U, Kiesel U, Kolb H. Administration of silica prevents diabetes in BB-rats. Diabetes 1985; 34: 197–199
   PubMed Web of Science ®Google Scholar
• Beutler B, Cerami A. Cachectin and tumour necrosis factor as two sides of the same biological coin. Nature 1986; 320: 584–588
   PubMed Web of Science ®Google Scholar
• Gray P W, Goeddel DV. Structure of the human immune interferon gene. Nature 1982; 298: 859–863
   PubMed Web of Science ®Google Scholar
• Zilberstein A, Ruggieri R, Korn J H, Revel M. Structure and expression of cDNA and genes for human interferon-β2, a distinct species inducible by growth-stimulatory cytokines. EMBO J 1986; 5: 2529–2537
   PubMed Web of Science ®Google Scholar
• Hirano T, Yasukawa K, Harada H, Taga T, Watanabe Y, Matsuda T, Kashiwamura S, Nakajima K, Koyama K, Iwamatsu A, Tsunasawa S, Sakiyama F, Matsui H, Takahara Y, Taniguchi T, Kishimoto T. Complementary DNA for a novel human interleukin (BSF-2) that induces B lymphocytes to produce immunoglobulin. Nature 1986; 324: 73–76
   PubMed Web of Science ®Google Scholar
• Aarden L, Lansdorp P, De Groot E. A growth factor for B cell hybridomas produced by human monocytes. Lymphokines 1985; 10: 175–185
   Google Scholar
• Van Damme J, Opdenakker G, Simpson R J, Rubira M R, Cayphas S, Vink A, Billiau A, Van Snick J. Identification of the human 26-kD protein, interferon β2 (IFN-β2), as a B cell hybridoma/plasmacytoma growth factor induced by interleukin 1 and tumor necrosis factor. J Exp Med 1987; 165: 914–919
   PubMed Web of Science ®Google Scholar
• Gauldie J. Interferon β2 is identical to HSF and regulates the full acute phase protein response in liver cells. Symposium IV; International Workshop on Monokines and Other Non-Lymphocytic Cytokines. Hilton Head Island. SC. USA Dec 6–10, 1987
   Google Scholar
• Bendtzen K, Petersen J, Halkjaer-Kristensen J, Ingemann-Hansen T. Interleukin-1-like activities in synovial fluids of patients with rheumatoid arthritis and traumatic synovitis. Rheumatol Int 1985; 5: 79–82
   PubMed Web of Science ®Google Scholar
• Browning J. Interferons and rheumatoid arthritis: insight into interferon biology. Immunol Today 1987; 8: 372–374
   PubMedGoogle Scholar
• Pettipher E R, Higgs G A, Henderson B. Interleukin 1 induces leukocyte infiltration and cartilage proteoglycan degradation in the synovial joint. Proc Natl Acad Sci USA 1986; 83: 8749–8753
   PubMed Web of Science ®Google Scholar
• Pettipher E R, Henderson B, Higgs G A, Moncada S. Arthritogenic activity of interleukin 1 in leucopaenic rabbits. Congress of the Int Assoc Biol Stand — Cytokines. LondonUK 1987
   Google Scholar
• Bendtzen K, Mandrup-Poulsen T, Nerup J, Nielsen J H, Dinarello C A, Svenson M. Human pI 7 interleukin 1 is cytotoxic for pancreatic islets of Langerhans. Science 1986; 232: 1545–1547
   PubMed Web of Science ®Google Scholar
• Mandrup-Poulsen T, Egeberg J, Nerup J, Bendtzen K, Nielsen J H, Dinarello CA. Ultrastructural studies of time-course and cellular specificity of interleukin-1 mediated islet cytotoxicity. Acta Pathol Microbiol Immunol Scand Sect C 1987; 95: 55–63
   PubMedGoogle Scholar
• Eizirik D L, Strandell E, Bendtzen K, Sandler S. Functional characteristics of rat pancreatic islets maintained in culture following exposure to human interleukin 1. Diabetes 1988, in press
   PubMed Web of Science ®Google Scholar
• Mandrup-Poulsen T, Bendtzen K, Dinarello C A, Nerup J. Human tumor necrosis factor potentiates human interleukin-1 mediated rat pancreatic β-cell cytotoxicity. J. Immunol 1987; 139: 4077–4082
   PubMed Web of Science ®Google Scholar
• Rasmussen ÅK, Bech K, Feldt-Rasmussen U, Poulsen S, Siersbaek-Nielsen K, Friis T, Bendtzen K. The influence of interleukin-1 on the function of in vitro cultured human thyroid cells in monolayers. Acta Endocrinol 1987; 281: 93–95, Suppl.
   Google Scholar
• Bendtzen K, Rasmussen ÅK, Bech K, Feldt-Rasmussen U, Egebjerg J. Cytokines in autoimmunity. Immunol Today 1987; 8: 203–204
   PubMedGoogle Scholar
• Spinas G A, Mandrup-Poulsen T, Mølvig J, Bæk L, Bendtzen K, Dinarello C A, Nerup J. Low concentrations of interleukin-1 stimulate and high concentrations inhibit insulin release from isolated rat islets of Langerhans. Acta Endocrinol 1986; 113: 551–558
   PubMedGoogle Scholar
• Bendtzen K, Rasmussen A K, Bech K, Feldt-Rasmussen U, Buschard K. Pathogenic role of interleukin 1 and tumor necrosis factor in autoimmune endocrine diseases. Clin Immunol Newslett 1988; 9: 72–74
   Google Scholar
• Dean B M, Walker R, Bone A J, Baird J D, Cooke A. Pre-diabetes in the spontaneously diabetic BB/E rat: lymphocyte subpopulations in the pancreatic infiltrate and expression of rat MHC class II molecules in endocrine cells. Diabetologia 1985; 28: 464–466
   PubMed Web of Science ®Google Scholar
• Nedwin GE, Naylor S, Sakaguchi A Y, Smith D, Jarrett-Nedwin J, Pennica D, Goeddel D V, Gray PW. Human lymphotoxin and tumor necrosis factor genes: structure, homology and chromosomal localisation. Nucl Acids Res 1985; 13: 6361–6373
   PubMed Web of Science ®Google Scholar
• Bendtzen K, Morling N, Fomsgaard A, Svejgaard A, Svenson M. Effect of HLA-D and -B region genes and interferon-γ on the in vitro. Production of tumor necrosis factor and interleukin-1, in press
   Google Scholar